The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma

Author： Singh Sundeep  

Publisher： Springer Publishing Company

ISSN： 0163-2116

Source： Digestive Diseases and Sciences, Vol.56, Iss.8, 2011-08, pp. : 2491-2496

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Utility of Serum CA19-9 Levels in the Diagnosis of Pancreatic Ductal Adenocarcinoma in an Endoscopic Ultrasound Referral Population

By Parikh Dhavan   Durbin-Johnson Blythe   Urayama Shiro  

Journal of Gastrointestinal Cancer, Vol. 45, Iss. 1, 2014-03 ,pp. : 74-79

Springer Publishing Company

Access to resources Recommend Favorite

Acute Cholecystitis with Significantly Elevated Levels of Serum Carbohydrate Antigen 19-9

By  

Case Reports in Gastroenterology, Vol. 10, Iss. 2, 2016-08 ,pp. : 410-416

Karger

Access to resources Recommend Favorite

CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer

By Luo Guopei   Xiao Zhiwen   Long Jiang   Liu Zuqiang   Liu Liang   Liu Chen   Xu Jin   Ni Quanxing   Yu Xianjun  

Journal of Gastrointestinal Surgery, Vol. 17, Iss. 12, 2013-12 ,pp. : 2092-2098

Springer Publishing Company

Access to resources Recommend Favorite

Gastric Cancer with a Very High Serum CA 19-9 Level

By  

Case Reports in Gastroenterology, Vol. 5, Iss. 1, 2011-04 ,pp. : 258-261

Karger

Access to resources Recommend Favorite

Spontaneously Ruptured Giant Splenic Cyst with Elevated Serum Levels of CA 19-9, CA 125 and Carcinoembryonic Antigen

By  

Case Reports in Gastroenterology, Vol. 4, Iss. 2, 2010-06 ,pp. : 191-197

Karger

Access to resources Recommend Favorite